Binding of glucagon and glucagon-stimulated cyclic AMP production were studied in highly purified liver plasma membranes from growing rats fed a 12% protein diet (group 1) or 20% protein diet; this latter was given either in normal (group 2) or restricted (group 3) amounts. Groups 2 and 3 exhibited significantly higher peripheral glucagonemia than group 1 (amounting to 286 and 160% of group 1, respectively). Specific [125I]iodoglucagon binding to plasma membranes was similar in all groups. Scatchard analysis revealed no further differences between affinity constants and binding capacities in the three groups. Hormone degradation was constant. As membrane recovery and membrane purity were unaltered, these results suggest that hyperglucagonemia caused by increasing dietary protein level is not associated with any significant modification of glucagon binding sites in rat liver. In the presence of a potent phosphodiesterase inhibitor (3-isobutyl-1-methyl xanthine 0.2 mM) the glucagon-stimulated cyclic AMP production was higher in rats fed the 20% protein diet, which was given in normal amounts, than in rats fed the 12% protein diet. In contrast when the 20% protein diet was given in restricted amounts the glucagon-stimulated cyclic AMP production was similar to that in the 12% protein-fed rats.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.